Allegiance Healthcare chooses Masimo oximeter:
This article was originally published in Clinica
Executive Summary
Allegiance Healthcare has selected the pulse oximetry sensor and signal-processing technology from privately-owned Irvine, California company, Masimo, to be incorporated into Allegiance monitors offered under its "Best Value" programme, to US hospitals. Allegiance hailed the Masimo signal-extraction pulse oximetry as giving fewer false alarms than other systems.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.